![](img/space.gif) |
Metabolikus eredetű retinadegenerációk és kivédési lehetőségek neuropeptidek és analógjaik segítségével
|
súgó
nyomtatás
|
Ezen az oldalon az NKFI Elektronikus Pályázatkezelő Rendszerében nyilvánosságra hozott projektjeit tekintheti meg.
vissza »![](img/space.gif)
![](img/space.gif)
![](img/space.gif)
![](img/space.gif)
|
![](img/print_ver.gif) |
Közleményjegyzék |
|
|
Reglodi D, Kiss P, Szabadfi K, Atlasz T, Gabriel R, Horvath G, Szakaly P, Sandor B, Lubics A, Laszlo E, Farkas J, Matkovits A, Brubel R, Hashimota H, Ferencz A, Vincze A, Helyes Z, Welke L, Lakatos A, Tamas A: PACAP is an endogenous neuroprotective factor – insights from PACAP deficient mice., J. Mol. Neurosci. 48, 482-492., 2012 | Szabadfi K, Atlasz T, Kiss P, Danyadi B, Tamas A, Helyes Zs, Hashimoto H, Shintani N, Baba A, Toth G, Gabriel R, Reglodi D: Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) are more susceptible to retinal ischemic injury in vivo., Neurotox. Res. 21, 41-48, 2012 | Tamas A, Szabadfi K, Nemeth A, Fülöp B, Kiss P, Atlasz T, Gabriel R, Hashimoto H, Baba A, Shintani N, Helyes Z, Reglodi D: Comparative examination of inner ear in wild type and pituitary acenylate cyclase activating polypeptide (PACAP deficient mice., Neurotox. Res. 21, 435-444., 2012 | Szabadfi K, Atlasz T; Kiss P; Reglodi D; Szabo A; Kovacs K; Szalontai B; Setalo G; Banki E; Csanaky K; Tamas A; Gabriel R: Protective effects of the neuropeptide PACAP in diabetic retinopathy, Cell Tissue Res. 348, 37-46., 2012 | Szabadfi K, Danyadi B, Kiss P, Tamas A, Fabian E, Gabriel R, Reglodi D: The protective effects of vasoactive intestinal peptide (VIP) in ischemic retinal degeneration, J Mol. Neurosci. 48, 501-507., 2012 | Szabadfi K, Danyadi B, Kiss P, Manavalan S, Gabriel R, Reglodi D, Tamas A, Trasy D, Batai I: Preconditioning with volatile aneaesthetic sevoflurane in ischemic retinal lesion in rats., J. Mol. Histol. 43, 565-569., 2012 | Szabo A, Danyadi B, Bognar E, Szabadfi K, Fabian E, Kiss P, Mester L, Manavalan S, Atlasz T, Gabriel R, Toth G, Tamas A, Reglodi D, Kovacs K: Effect of PACAP on MAP kinases, Akt and cytokine expressions in rat retinal hypoperfusion., Neurosci. Lett. 523, 93-98., 2012 | Lakk M, Czotter N, Volgyi B, Gábriel R, Dénes V (2012): Development-related splicing regulates pituitary adenylate cyclase-activating polypeptide (PACAP) receptors in the retina., Invest Ophthalmol Vis Sci. 53, 7825-7832., 2012 | Reglodi D, Kiss P, Szabadfi K, Atlasz T, Gabriel R, Horvath G, Szakaly P, Sandor B, Lubics A, Laszlo E, Farkas J, Matkovits A, Brubel R, Hashimota H, Ferencz A, Vincze A, Helyes Z, Welke L, Lakatos A, Tamas A: PACAP is an endogenous neuroprotective factor – insights from PACAP deficient mice., J. Mol. Neurosci. 48, 482-492., 2012 | Szabadfi K, Atlasz T, Kiss P, Danyadi B, Tamas A, Helyes Zs, Hashimoto H, Shintani N, Baba A, Toth G, Gabriel R, Reglodi D: Mice deficient in pituitary adenylate cyclase activating polypeptide (PACAP) are more susceptible to retinal ischemic injury in vivo., Neurotox. Res. 21, 41-48, 2012 | Szabadfi K, Atlasz T; Kiss P; Reglodi D; Szabo A; Kovacs K; Szalontai B; Setalo G; Banki E; Csanaky K; Tamas A; Gabriel R: Protective effects of the neuropeptide PACAP in diabetic retinopathy, Cell Tissue Res. 348, 37-46., 2012 | Szabadfi K, Danyadi B, Kiss P, Tamas A, Fabian E, Gabriel R, Reglodi D: The protective effects of vasoactive intestinal peptide (VIP) in ischemic retinal degeneration, J Mol. Neurosci. 48, 501-507., 2012 | Szabadfi K, Danyadi B, Kiss P, Manavalan S, Gabriel R, Reglodi D, Tamas A, Trasy D, Batai I: Preconditioning with volatile aneaesthetic sevoflurane in ischemic retinal lesion in rats., J. Mol. Histol. 43, 565-569., 2012 | Szabo A, Danyadi B, Bognar E, Szabadfi K, Fabian E, Kiss P, Mester L, Manavalan S, Atlasz T, Gabriel R, Toth G, Tamas A, Reglodi D, Kovacs K: Effect of PACAP on MAP kinases, Akt and cytokine expressions in rat retinal hypoperfusion., Neurosci. Lett. 523, 93-98., 2012 | Lakk M, Czotter N, Volgyi B, Gábriel R, Dénes V (2012): Development-related splicing regulates pituitary adenylate cyclase-activating polypeptide (PACAP) receptors in the retina., Invest Ophthalmol Vis Sci. 53, 7825-7832., 2012 | Kiss P, Szabadfi K, Horvath G, Tamas A, Farkas J, Gabriel R, Reglodi D: Gender-dependent effects of enriched environment and social isolation in ischemic retinal lesion in adult rats., Int. J. Mol. Sci. 14, 16111-16123, 2013 | Szabadfi K, Kiss P, Reglodi D, Fekete EM, Tamas A, Danyadi B, Atlasz T, Gábriel R (2013): Urocortin 2 treatment is protective in excitotoxic retinal degeneration., Acta Physiol. Hung. (in press), 2013 | Gábriel R: Neuropeptides and diabetic retinopathy, Brit. J. Clin. Pharmacol. 75, 1189-1201, 2013 | Völgyi B, Kovács-Öller T, Atlasz T, Wilhelm M3, Gábriel R.: Gap Junctional Coupling in the Vertebrate Retina: variations on one theme?, Prog. Retinal Eye Res. 34, 1-18., 2013 | Szabadfi K, Kiss P, Reglodi D, Fekete EM, Tamas A, Danyadi B, Atlasz T, Gábriel R: Urocortin 2 treatment is protective in excitotoxic retinal degeneration., Acta Physiol. Hung. 101, 67-76, 2014 | Nemeth A, Szabadfi K, Fulop B, Reglodi D, Kiss P, Farkas J, Szalontai B, Gabriel R, Hashimoto H, Tamas A: Examination of calcium-binding protein expression in the inner ear of wild type, heterozygous and homozygous pituitary adenylate cyclase activating polypeptide (PACAP)-, Neurotox. Res. 25, 57-67, 2014 | Dénes V, Czotter N, Lakk M, Berta G, Gábriel R: PAC1 expressing structures of the neural retina alter their PAC1 isoform splicing during postnatal development, Cell Tissue Res. 355, 279-288, 2014 | Szabadfi K, Szabo A, Kiss P, Reglodi D, Setalo Jr G, Kovacs K, Tamas A, Toth G, Gabriel R: PACAP promotes neuron survival in early experimental diabetic retinopathy, Neurochem. Int. 64, 84-91., 2014 | Danyadi B, Szabadfi K, Reglodi D, Mihalik A, Danyadi T, Kovacs Zs, Batai I, Tamas A, Kiss P, Toth G, Gabriel R: PACAP application improves functional outcome of chronic retinal ischemic injury in rats - evidence from electroretinographic measurements, J. Mol. Neurosci. 54, 293-299, 2014 | Szabadfi K, Pintér E, Reglodi D, Gábriel R: Neuropeptides, trophic factors and other substances providing morphofunctional and metabolic protection in experimental models of diabetic retinopathy, Int. Rev. Cell Mol. Biol. 331, 1-121., 2014 | Lakk Mónika: A hipofízis adenilát-cikláz aktiváló polipeptid anti-apoptotikus és ontogenetikus hatása a posztnatális patkány retinában, Pécsi Tudományegyetem Biológiai Doktori Iskola, Szabályozásbiológiai Program, 2014 | Wilhelm M, Lawrence JJ, Gábriel R: Enteric plexuses of two chline-acetyltransferase transgenic mouse lines: chemical neuroanatomy of the fluorescent protein-expressing nerve cells, Brain Research Bulletin 111, 76-83., 2015 | Yi F, Catudio-Gerrett E, Gabriel R, Wilhelm M, Erdelyi F, Szabo G, Deisseroth K, Lawrence JJ: Hippocampla "cholinergic interneurons" visualized with the choline acetyltransferaser promoter: anatomical distribution, intrinsic membrane properties, neurochemical char, Frontiers in Synaptic Neuroscience 7, 4., 2015 | Szabadfi K, Estrada C, Fernandez-Vilalba E, Tarragon E, Setalo G, Izura V, Reglodi D, Tamas A, Gabriel R, Herrero MT: Retinal aging in the diurnal chilean rodent (Octodon degus): histological, ultrastructural and neurochemical alterations of the vertical information processing pathway, Frontiers in Cellular Neuroscience 9, 126., 2015 | Lakk M, Dénes V, Gabriel R: Pituitary Adenylate Cyclase-Activating Polipeptide receptors signl via phospholipase C pathway to block apoptosis, Neurochemical Research 40, 1402-1409., 2015 | Szabadfi K, Reglodi D, Szabo A, Szalontai B, Valasek A, Setalo Gm Kiss P, Tamas A, Wilhelm M, Gabriel R: Pituitary adenylate cyclase-activating polypeptide, a potential therapeutic agent for diabetic retinopathy in rats: focus oin the vertical information processing pathway, Neuortoxicity Research DOI 10.1007/s12640-015-9593-1, 2016 | Szabadfi K, Reglodi D, Szabo A, Szalontai B, Valasek A, Setalo Gm Kiss P, Tamas A, Wilhelm M, Gabriel R: Pituitary adenylate cyclase-activating polypeptide, a potential therapeutic agent for diabetic retinopathy in rats: focus oin the vertical information processing pathway, Neuortoxicity Research 29, 432-445., 2016 | Gábriel R, Erdélyi F, Szabó G, Lawrence JJ, Wilhelm M: Ectopic transgene expression in the retina of four transgenic mouse lines, Brain Structure and Function 221, 3729-3741., 2016 | Hajna Z, Szabadfi K, Ball Z, Bíró Z, Degrell O, Molnár GA, Kőszsegi T, Tékus V, Helyes Z, Dobos A, Farkas S, Szűcs G, Gábriel R, Pintér E: Modeling long-term diabetes and related complications in rats, J Pharmacol Toxicol Meth 78, 1-12, 2016 |
![](img/space.gif)
|
|
|
![](img/shadow_right_up.gif)
|
![](img/shadow_left_bottom.gif)
|
![](img/shadow_right_bottom.gif)
|
![](img/space.gif)
vissza »
|
![](img/space.gif) |
|